טוען...
Terminal Maturation of Orthochromatic Erythroblasts Is Impaired in Burn Patients
Mechanisms of erythropoietin (Epo)–resistant anemia in burn patients are poorly understood. We have recently found that administering a nonselective beta 1,2-adrenergic blocker propranolol (PR) was effective in reversing myelo-erythroid commitment through MafB regulation and increase megakaryocyte e...
שמור ב:
| הוצא לאור ב: | J Burn Care Res |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5709235/ https://ncbi.nlm.nih.gov/pubmed/28570310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/BCR.0000000000000592 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|